Dyno Therapeutics co-founder Sam Sinai describes research using machine learning to design viral carriersAI-assisted scientific discovery uses AI to support hypothesis generation, experiment design, analysis, simulation, literature work, and interpretation while researchers retain responsibility. for delivering genetic material to specific tissues. He explains why reaching intended cells while limiting delivery elsewhere is a difficult problem.
Sam Sinai describes a reported non-human primate result involving delivery to neurons across the blood-brain barrier. This is a research claim in animalsExperimental validation tests a prediction or proposed mechanism with measured observations from a suitable real-world or laboratory experiment. and does not establish a proven treatment in people.
The conversation also addresses the potential misuse of powerful biological toolsAI safety is the field and practice of reducing harmful failures, misuse, loss of control, and unintended consequences from AI systems.. Sam Sinai advocates considering safeguards and investing in infrastructure for medical response while preserving useful research.
Watch on YouTube
